Now showing items 1-2 of 2

    • Milos, Ioana N.; Frank-Raue, Karin; Wohllk, Nelson; Maia, Ana Luiza; Pusiol, Eduardo; Patocs, Attila; Robledo, Mercedes; Biarnes, Josefina; Barontini, Marta; Links, Thera P.; de Groot, Jan Willem; Dvorakova, Sarka; Peczkowska, Mariola; Rybicki, Lisa A.; Sullivan, Maren (2008)
      RET testing in multiple endocrine neoplasia type 2 for molecular diagnosis is the paradigm for the practice of clinical cancer genetics. However, precise data for distinct mutation-based risk profiles are not available. ...
    • Castinetti, Frederic; Waguespack, Steven G.; Machens, Andreas; Uchino, Shinya; Hasse-Lazar, Kornelia; Sanso, Gabriella; Else, Tobias; Dvorakova, Sarka; Qi, Xiao Ping; Elisei, Rossella; Maia, Ana Luisa; Glod, John; Lourenço, Delmar Muniz; Valdes, Nuria; Mathiesen, Jes (Lancet Publishing Group, 2019)
      © 2019 Elsevier LtdBackground: Multiple endocrine neoplasia type 2B is a rare syndrome caused mainly by Met918Thr germline RET mutation, and characterised by medullary thyroid carcinoma, phaeochromocytoma, and extra-endocrine ...